Hellman Jordan Management CO Inc Biogen Inc. Transaction History

Hellman Jordan Management CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 28, 2020	SELL	$268.85 - $341.04 $2.23 Million - $2.83 Million	-8,293 Closed	0 $0
Q4 2019 Feb 21, 2020	BUY	$220.06 - $304.07 $1.16 Million - $1.61 Million	5,293 Added 176.43%	8,293 $2.46 Million
Q2 2019 Aug 19, 2019	BUY	$219.29 - $241.72 $657,870 - $725,160	3,000 New	3,000 $702,000
Q2 2018 Aug 21, 2018	SELL	$257.52 - $306.91 $500,103 - $596,019	-1,942 Closed	0 $0
Q4 2017 Mar 01, 2018	BUY	$307.64 - $344.58 $2,461 - $2,756	8 Added 0.41%	1,942 $619,000
Q3 2017 Dec 04, 2017	BUY	$281.15 - $329.69 $543,744 - $637,620	1,934	1,934 $606,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Hellman Jordan Management CO Inc , based on Form 13F filings with the SEC.

Stay updated on Hellman Jordan Management CO Inc with notifications on news.